For five years, a pharmacist in Bengaluru sold counterfeit cancer medications to over ninety prestigious institutions at 50% lower prices without being discovered .

He was the owner of Krupa Healthcare and went as Veeresh Kumar Jain.

According to police, the scheme would take less expensive or outdated medications, repackage them in new containers, label them with well-known pharmaceutical brands, and then use more than fifteen medical representatives to reintroduce them into the hospital supply chain.

Counterfeit pharmaceuticals worth about ₹5 crore had been confiscated by the time it was busted.


Because when cancer has already depleted your savings, that discount affects you in a completely different way. In the interim,
One in nine Indians will get cancer at some point in their lives. The average annual out-of-pocket medical expenses are ₹3.31 lakh, with medications accounting for about 45% of that amount.

Families sell valuables, pawn jewelry, and take out loans from moneylenders. Not just the patient but the entire household may become impoverished after receiving a cancer diagnosis.
Furthermore, patients are unable to confirm the contents of an injection. Lab testing cannot be performed by families prior to each drip.

They have faith in the hospital. The distributor is trusted by the hospital. The provider is trusted by the distributor.

In this case, trust is the actual product.

Furthermore, a single pharmacy owner is not the issue if counterfeit medications can pass through more than 90 hospitals in five states before being discovered.

It was made possible by every weakness in the system.

Indian families are already forced to choose between someone's life and their savings due to cancer.

Making ensuring the medication is authentic is the least we can do.